Western blotting indicated that the intracisternal administration of TNF-α antibody, but not vehicle, attenuated the upregulated RIPK1 expression in the TSC, resulting from the inferior alveolar nerve injury on POD 3 (p < 0.05, Figure 4C). The gene discussed is RIPK1; the disease is tuberous sclerosis.